Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma

Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma

The aggressive biology of pancreatic ductal adenocarcinoma (PDAC), along with its limited sensitivity to many systemic therapies, presents a major challenge in the management of patients with metastatic PDAC. Over the past decade, the incorporation of combinatorial cytotoxic chemotherapy regimens ha...

Full description

Bibliographic Details
Main Authors: Brandon M. Huffman, Haley Ellis, Alexander C. Jordan, William A. Freed-Pastor, Kimberly Perez, Douglas A. Rubinson, Nilay Sethi, Harshabad Singh, Rishi Surana, Brian M. Wolpin, Andrew J. Aguirre, James M. Cleary
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
pancreatic adenocarcinoma
precision medicine
targeted therapy
DNA repair inhibitors
Online Access:https://www.mdpi.com/2072-6694/14/24/6223

Internet

https://www.mdpi.com/2072-6694/14/24/6223

Similar Items